The metabolism of 2- and 4-fluoro-17β- oestradiol in the rat and its implications for oestrogen carcinogenesis
- 3 March 1992
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 43 (5) , 985-993
- https://doi.org/10.1016/0006-2952(92)90603-g
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Nephrocarcinogenicity of estrogensToxicology Letters, 1990
- ORAL CONTRACEPTIVE USE AND MALIGNANCIES OF THE GENITAL TRACTThe Lancet, 1988
- Cervical adenocarcinoma and oral contraceptives.BMJ, 1987
- Adverse long‐term effects of oral contraceptives: a reviewBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- The biliary and urinary metabolites of [3H]17α-ethynylestradiol in womenXenobiotica, 1983
- Clear cell adenocarcinoma and the current status of DES-exposed femalesCancer, 1981
- Cytochrome P-450-mediated oxidation of 2-hydroxyestrogens to reactive intermediatesBiochemical and Biophysical Research Communications, 1976
- Biliary metabolites of 14C-estrone and 14C-estradiol from the ratSteroids, 1971
- Vaginal Cancer after Maternal Treatment with Synthetic EstrogensNew England Journal of Medicine, 1971
- Metabolism of Radioactive Estrone and Estradiol by the Golden HamsterEndocrinology, 1967